To determine if upregulated CEMIP in invaded colon cancer cells coincides with changes associated with the EMT phenotype, E-cadherin, a marker commonly lost during EMT, was examined using an anti-E-cadherin antibody. Here, CEMIP is linked to malignant colon neoplasm.